(Q44249118)

1 December 2017

title

Effect of low-, moderate-, and high-fat meals on raltegravir pharmacokinetics (English)

1 reference

1 December 2017

1 reference

1 reference

4

1 reference

1 December 2017

Diana M Brainard

1

1 reference

1 December 2017

Evan J Friedman

2

1 reference

1 December 2017

Bo Jin

3

1 reference

1 December 2017

Maria D Tillan

5

1 reference

1 December 2017

Larissa A Wenning

6

1 reference

1 December 2017

Julie A Stone

7

1 reference

1 December 2017

Jeffrey A Chodakewitz

8

1 reference

1 December 2017

John A Wagner

9

1 reference

1 December 2017

Marian Iwamoto

10

1 reference

1 December 2017

publication date

10 May 2010

1 reference

The Journal of Clinical Pharmacology

1 December 2017

published in

1 reference

1 December 2017

volume

51

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

422-427

1 reference

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

Association of gastric hypoacidity with opportunistic enteric infections in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

No relationship between gastric pH, small bowel bacterial colonisation, and diarrhoea in HIV-1 infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010367652

21 January 2018

Identifiers

DOI

10.1177/0091270010367652

1 reference

1 December 2017

1 reference